文献速递前列腺癌

MRUSuNet多模态AI模型提升前列腺癌TRUS定位精度

An artificial intelligence model combining MRI and ultrasound images (MRUSuNet) for prostate cancer detection outperforms radiologist MRI interpretation.
PubMed 文献 · BJU Int · 2026-10-20

本研究开发了结合MRI与经直肠超声(TRUS)的MRUSuNet模型,用于在TRUS图像上检测并三维定位临床显著前列腺癌。模型在两个融合穿刺队列(3000例)中开发,在前列腺根治切除队列(110例)中独立验证。结果显示其敏感性和病灶Dice评分均优于单模态模型,且特异性高于放射科医生解读。

要点

  • MRUSuNet在测试队列中敏感性0.80、病灶Dice评分0.42,优于MRI单模态和TRUS单模态模型。
  • 在前列腺切除队列中,MRUSuNet特异性0.88高于放射科医生的0.78,病灶Dice评分也更高。
  • 该多模态AI模型有望作为MRI-TRUS融合工作流程的辅助工具,改善前列腺癌定位。

核心结论

  • 结合MRI与TRUS的多模态AI模型(MRUSuNet)能改善临床显著前列腺癌在TRUS图像上的定位,效果优于单模态模型。

研究设计与样本

  • 研究纳入两个MRI-TRUS融合穿刺队列共3000例患者用于模型开发。
  • 另设一个前列腺根治切除队列110例用于独立验证及与放射科医生解读比较。
  • 预留1700例独立病例用于比较MRUSuNet与MRI-only及TRUS-only模型。

主要发现

  • MRUSuNet在所有测试队列中敏感性为0.80,病灶Dice评分为0.42。
  • MRI-only模型敏感性0.73(P=0.033)、Dice评分0.30(P<0.001);TRUS-only模型敏感性0.49(P<0.001)、Dice评分0.27(P<0.001)。
  • 在前列腺切除队列中,MRUSuNet特异性0.88 vs 放射科医生0.78(P=0.004),病灶Dice评分0.32 vs 0.27(P=0.048),敏感性0.79无统计学差异(P=1.000)。

关键数值与推荐

  • 敏感性定义为以靶向穿刺病理(穿刺队列)或全 mount 前列腺切除病理(根治队列)为参考标准计算。
  • 病灶级Dice相似度评分用于评估三维空间定位准确性。

临床怎么用

  • MRUSuNet可作为MRI-TRUS融合穿刺流程的辅助工具,提升TRUS图像上临床显著前列腺癌的可视化与定位。
  • 该模型在前列腺切除队列中特异性高于放射科医生解读,可能减少假阳性定位。

局限性

  • 原文未报告模型在前瞻性临床工作流程中的实时性能数据。
  • 原文未报告不同操作者间变异或外部多中心验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop the magnetic resonance imaging (MRI)-UltraSound UNet (MRUSuNet), a model that uses both MRI and transrectal ultrasonography (TRUS) as input to detect and localise the three-dimensional spatial volume of clinically significant prostate cancer on TRUS images to allow better visualisation of cancer in the TRUS space. PATIENTS AND METHODS: Pre-biopsy MRI is increasingly used to target suspicious prostate lesions. The lesions identified by radiologists are mapped onto TRUS images to enable real-time targeting during the biopsy. Yet, the misalignment of MRI and TRUS results in sampling errors, and in some cases even missing the clinically significant cancers. This study included two MRI-TRUS fusion biopsy cohorts (3000 patients) for model development, and one radical prostatectomy cohort (110 patients) used for independent validation and for the comparison with radiologist interpretation. A total of 1700 independent cases were reserved to compare the MRUSuNet with single-modality MRI-only and TRUS-only models. Sensitivity and lesion-level Dice similarity scores were computed using targeted biopsy pathology as the reference standard in the biopsy cohorts and whole-mount prostatectomy pathology in the radical prostatectomy cohort. RESULT: The MRUSuNet achieved significantly superior sensitivity (0.80) and lesion Dice score (0.42) across all test cohorts compared to the MRI-only model (sensitivity: 0.73, P = 0.033; Dice score: 0.30, P < 0.001) and the TRUS-only model (sensitivity: 0.49, P < 0.001; Dice score: 0.27, P < 0.001). Compared to radiologists in the prostatectomy cohort, the MRUSuNet showed significantly higher specificity (0.88 vs 0.78; P = 0.004) and lesion Dice score (0.32 vs 0.27; P = 0.048), with no observed statistical difference in sensitivity (0.79; P = 1.000). CONCLUSION: Our findings demonstrate the potential of combining MRI and TRUS in a multimodal artificial intelligence (AI) model to improve localisation of clinically significant prostate cancer on TRUS images relative to single-modality models. These findings support further study of such multimodal AI models as an adjunct to MRI-TRUS fusion workflows.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Jahanandish H, Sang S, Li CX, et al. An artificial intelligence model combining MRI and ultrasound images (MRUSuNet) for prostate cancer detection outperforms radiologist MRI interpretation. BJU Int. 2026. PMID: 42901865. doi:10.1111/bju.70491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。